These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8315960)

  • 21. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners.
    Sonnenberg P; Glynn JR; Fielding K; Murray J; Godfrey-Faussett P; Shearer S
    J Infect Dis; 2005 Jan; 191(2):150-8. PubMed ID: 15609223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Patients with human immunodeficiency virus admitted to the emergency service of a general hospital].
    Iglesias ML; Pedro-Botet J; Hernández E; Villalta R; Alvarez A; Gutiérrez J; Skaf E
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):468-72. PubMed ID: 9527371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire.
    Braun MM; Badi N; Ryder RW; Baende E; Mukadi Y; Nsuami M; Matela B; Willame JC; Kaboto M; Heyward W
    Am Rev Respir Dis; 1991 Mar; 143(3):501-4. PubMed ID: 2001057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of tuberculosis and HIV infections among participants in an intravenous drug user risk-control program].
    Alvarez Rodríguez M; Godoy García P
    Rev Esp Salud Publica; 1999; 73(3):375-81. PubMed ID: 10479959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
    Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
    AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mantoux reaction in patients with HIV-related pulmonary tuberculosis in Maiduguri, Nigeria.
    Yusuph H; Garbati MA; Gashau W
    Afr J Med Med Sci; 2005 Jun; 34(2):125-8. PubMed ID: 16749335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of human immunodeficiency virus infection in 67 patients with tuberculosis].
    Beaulieu P; Molina JM; Rouveau M; Garrait V; Casin I; Doco-Lecompte T; Lagrange P; Decazes JM; Modaï J
    Ann Med Interne (Paris); 1993; 144(5):323-8. PubMed ID: 8291841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection.
    Semba RD; Graham NM; Caiaffa WT; Margolick JB; Clement L; Vlahov D
    Arch Intern Med; 1993 Sep; 153(18):2149-54. PubMed ID: 8379807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of intravenous drug abuse on vascular access placement and survival in HIV-seropositive patients.
    Eustace JA; Gregory PC; Krishnan M; Ni W; Kuhn DM; Astor BC; Scheel PJ
    Nephron Clin Pract; 2005; 100(2):c38-45. PubMed ID: 15818057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of HIV seroprevalence in patients with pulmonary tuberculosis in 1999 in Chad].
    Tosi CH; Ngangro MN; Djimadoum N; Richard V
    Med Trop (Mars); 2002; 62(6):627-33. PubMed ID: 12731312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pattern of human immunodeficiency virus infection (HIV) in pulmonary tuberculosis patients in Jos, Nigeria.
    Anteyi EA; Idoko JA; Ukoli CO; Bello CS
    Afr J Med Med Sci; 1996 Dec; 25(4):317-21. PubMed ID: 9532299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset].
    Egea JM; Tor J; Muga R; Roca J; Rodríguez R; Navío M; Rey-Joly C
    Med Clin (Barc); 1996 Jan; 106(3):87-90. PubMed ID: 8948942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HIV-positive drug addicts treated at the Copenhagen City Drug Dependency Clinic 1986-1992].
    Hjorther AB; Andersen LB; Hetmar O; Jepsen PW
    Ugeskr Laeger; 1994 May; 156(20):3028-32. PubMed ID: 8023410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency].
    Mary-Krause M; Rabaud C; Jouan M; Obadia M; de la Blanchardière A; Raffi F; May T
    Pathol Biol (Paris); 2000 Jun; 48(5):495-504. PubMed ID: 10949848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.
    Backmund M; Meyer K; Henkel C; Reimer J; Wächtler M; Schütz CG
    Eur Addict Res; 2005; 11(3):138-44. PubMed ID: 15990431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation between mantoux and tuberculin's fraction from delayed hypersensitivity skin test, in a cohort from HIV-1 positive patients, in function of immunodeficiency level, and active tuberculosis incidence].
    Cabarcos Ortiz de Barrón A; Barrio Gómez E; Lado Lado FL; Rodríguez López I; Lorenzo Zúñiga V
    An Med Interna; 2000 Dec; 17(12):632-6. PubMed ID: 11213577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium tuberculosis infection among crack and injection drug users in San Juan, Puerto Rico.
    Reyes JC; Robles RR; Colón HM; Marrero CA; Castillo X; Meléndez M
    P R Health Sci J; 1996 Sep; 15(3):233-6. PubMed ID: 8994290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.